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to particulate exposure in a murine model
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Shinji Takenaka2, Wolfgang G Kreyling2,3 and Holger Schulz2,4Abstract
Background: Persons with cystic fibrosis (CF) are at-risk for health effects from ambient air pollution but little is
known about the interaction of nanoparticles (NP) with CF lungs. Here we study the distribution of inhaled NP in a
murine CF model and aim to reveal mechanisms contributing to adverse effects of inhaled particles in susceptible
populations.
Methods: Chloride channel defective CftrTgH (neoim) Hgu mice were used to analyze lung function, lung distribution
and whole body biokinetics of inhaled NP, and inflammatory responses after intratracheal administration of NP.
Distribution of 20-nm titanium dioxide NP in lungs was assessed on ultrathin sections immediately and 24 h after a
one-hour NP inhalation. NP biokinetics was deduced from total and regional lung deposition and from whole body
translocation of inhaled 30-nm iridium NP within 24 h after aerosol inhalation. Inflammatory responses were
assessed within 7 days after carbon NP instillation.
Results: Cftr mutant females had moderately reduced lung compliance and slightly increased airway resistance
compared to wild type mice. We found no genotype dependent differences in total, regional and head deposition
or in secondary-organ translocation of inhaled iridium NP. Titanium dioxide inhalation resulted in higher NP uptake
by alveolar epithelial cells in Cftr mutants. Instillation of carbon NP induced a comparable acute and transient
inflammatory response in both genotypes. The twofold increase of bronchoalveolar lavage (BAL) neutrophils
in Cftr mutant compared to wild type mice at day 3 but not at days 1 and 7, indicated an impaired capacity in
inflammation resolution in Cftr mutants. Concomitant to the delayed decline of neutrophils, BAL granulocyte-colony
stimulating factor was augmented in Cftr mutant mice. Anti-inflammatory 15-hydroxyeicosatetraenoic acid was generally
significantly lower in BAL of Cftr mutant than in wild type mice.
Conclusions: Despite lacking alterations in lung deposition and biokinetics of inhaled NP, and absence of significant
differences in lung function, higher uptake of NP by alveolar epithelial cells and prolonged, acute inflammatory responses
to NP exposure indicate a moderately increased susceptibility of lungs to adverse effects of inhaled NP in Cftr mutant
mice and provides potential mechanisms for the increased susceptibility of CF patients to air pollution.
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Air pollution continues to be a major threat to human
health, accounting for an estimated 3.7 million premature
deaths in 2012 [1]. The association between exposure to air
pollution, especially to airborne particulate matter (PM),
and a wide range of adverse health effects, particularly re-
spiratory and cardiovascular effects, has been established by
plentiful epidemiologic evidence, supported by mechanistic
in vivo animal studies [2-4]. The susceptible populations are
children, women in the reproductive age, the elderly and
persons with pre-existing respiratory and cardiovascular dis-
eases. While many studies have focused on the interaction
of PM with asthma or chronic obstructive pulmonary dis-
ease (COPD) [5], relatively little is known about PM effects
in patients with cystic fibrosis (CF).
Cystic fibrosis (CF) is caused by mutations in the gene
encoding the CF transmembrane conductance regulator
(CFTR) and results in altered ion transport regula-
tion across epithelial membranes [6]. In lungs, defective
CFTR leads to hyperviscous, adhesive airway mucus and
ultimate failure of mucociliary clearance [7]. Recurrent
infections with CF-specific bacteria with intense inflam-
matory responses contribute to irreversible lung injury
[8]. The fine pulmonary structure of newborn CF infants
is assumed to be normal. However, it has been suggested
that the beginning of lung disease might precede the
colonization with CF-related pathogens [9]. Further-
more, a significant heterogeneity in the severity of lung
disease is observed in patients carrying the same muta-
tion; the basis for the divergence between genotype and
lung phenotype has been attributed to modifier genes,
but also to environmental factors [10,11]. Evidence for a
relationship between PM10 and PM2.5 pollution and pul-
monary disease in CF was found in a cohort study with
higher rates of pulmonary exacerbations in CF patients
[12]. Potential mechanisms discussed are changes in the
breathing pattern, which result in increased particle de-
position in CF patients [13], or alterations of mucociliary
and/or macrophage-mediated particle clearance [14,15].
Beside PM10 and PM2.5, ultrafine or nanoparticles
(UFP, NP, particles with diameters < 100 nm) are of in-
creasing concern [16]. Adverse health effects occur at
current levels of exposure, and no threshold concentra-
tion has been identified below which air pollution poses
no risk for human health [17,18]. In addition, nanotech-
nology industry generates daily new NP, which may be-
come airborne at some stage of their life cycle and thus
pose additional health risks.
There is evidence for decreased NP clearance from lungs
of patients with chronic obstructive pulmonary disease
(COPD) [19] and for impaired NP uptake by macrophages
in COPD mice [20]. Hence, there are several factors which
may contribute to an enhanced susceptibility of CF lungs
to adverse effects of inhaled NP.To evaluate individual factors and multifactorial as-
pects that may lead to enhanced susceptibility in CF
lungs (Figure 1A), we investigated in a comprehensive
approach (Figure 1B):
1. The distribution and clearance of inhaled 20-nm
titanium dioxide NP (TiO2NP) at the individual
particle level using analytical transmission electron
microscopy (TEM) in chloride channel defective
CftrTgH (neoim) Hgu mice in comparison to wild type
(WT) littermates [21].
2. Inhaled radio-labeled iridium NP (IrNP) served to
assess the biokinetics of NP.
3. We examined lung function, since its alteration may
affect intrapulmonary particle deposition.
4. Lung exposure to carbon NP (CNP), an abundant
component of urban, particulate air pollution served
to evaluate the inflammatory responses as biological
outcome.
Results
Lung physiology and fine pulmonary structures
Lung function data are summarized in Table 1. In general,
body weight (BW) was lower in females than in males, but
comparable among Cftr mutant and WT mice. In accord-
ance with morphological studies [22,23], the mutation had
no effect on lung size (TLC, total lung capacity), both, for
absolute values and when expressed in relation to BW
(TLC/BW). Similarly, the conducting airway volume (VD,
series dead space volume) and its relative proportion to
lung size (VD/TLC), as well as the gas exchanging capacity
across the alveolar capillary membrane (DCO, diffusing cap-
acity for carbon monoxide CO) were not altered, the latter
also not when accounting for the alveolar volume (VA,
DCO/VA). However, female Cftr mutants showed about
20% reduced respiratory system (CRS) and lung compliance
(CL) values and an increased respiratory system resistance
(R) compared to WT mice. These differences remained sta-
tistically significant when related to lungs size (CRS/TLC,
CL/TLC, and specific respiratory system resistance, sR (R ×
TLC), respectively). Thus, the lungs of 3 months old female
Cftr mutants are somewhat less distensible and put more
resistance to airflow during breathing, which results in an
increased work of breathing. Lung function of heterozygous
females was not significantly affected, although there was a
trend to limited compliance and resistance values. In male
animals, differences between WT and Cftr mutant mice
were noticeably for lung compliance (CL) and resistance
(R), but they were of lower extent (10%) than in females
and failed to be statistically significant.
Also in agreement with the above mentioned morpho-
logical studies [22,23], we found no statistically signifi-
cant differences in any of the lung structure parameters
analyzed between Cftr mutant and WT mice. The lung
Figure 1 Study motivation and experimental design. A) Individual factors and multifactorial aspects for enhanced susceptibility of CF lungs to
PM exposure. B) Time frame for lung function measurements, treatments with NP and subsequent analyses. CNP-Instillation: intratracheal instillation of
carbon nanoparticles; BALF: Bronchoalveolar lavage fluid.
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12.4– 19.8%). This pulmonary tissue consisted of 40.2 ±
6.7% connective tissue (range 33.3 – 46.8%), 33.4 ± 12.6%
capillaries (range 19.1– 43.3%) and 26.4 ± 9.2% epithelial
cells (range 16.2– 34.1%). In WT mice, 15.3 ± 2.3% was
lung tissue (range 12.7 – 17.1%), which was composed of
27.8 ± 4.6% connective tissue (range 22.9– 31.9%), 42.3 ±
6.6% capillaries (range 34.8 – 46.4%) and 29.9 ± 4.3% epi-
thelial cells (range 25.0– 33.3%).Cellular uptake of inhaled TiO2NP
A total of 469 - 659 hexagonal fields (equal to a volume of
6100 – 8600 μm3) on ultrathin lung sections were analyzed
per animal for the presence of TiO2NP. Particles were first
identified and morphologically localized by energy filteringtransmission electron microscopy (EFTEM). NP uptake
was further assessed by quantitative morphometry.
In Cftr mutants, we found a total of 8 TiO2 particles
intracellularly, namely 5 NP in alveolar epithelial type 2
cells and 3 NP in macrophages, while in WT mice 7 parti-
cles were found, all in macrophages. Additional subsamp-
ling and analysis of 83 - 110 macrophages (on 2208– 3260
hexagonal fields) per animal revealed 11 TiO2NP in Cftr
mutants and 11 in WT mice. Hence, TiO2NP were found
in alveolar type 2 epithelial cells as well as in macrophages
in Cftr mutants and in macrophages only in WT mice
(Table 2).
In animals of both genotypes, TiO2NP were found in
vesicles largely exceeding NP size (Figure 2, Table 2).
Thus, the ratio of particle to vesicle size RV/P, which allows
discrimination of endocytic uptake mechanisms [14,24],
Table 1 Lung function measurements in 14-weeks old mice
Sex Female Male
Genotype WT Cftr+/− Cftr−/− WT Cftr+/− Cftr−/−
N 8 11 8 8 8 8
BW (g) 22.8 ± 1.8 21.7 ± 1.4 22.5 ± 1.9 32.0 ± 2.4 31.2 ± 1.8 29.5 ± 3.3
TLC (mL) 1.23 ± 0.12 1.21 ± 0.10 1.18 ± 0.09 1.28 ± 0.08 1.29 ± 0.06 1.30 ± 0.14
TLC/BW (μL/g) 54.4 ± 3.7 56.0 ± 3.6 52.8 ± 3.6 40.2 ± 2.9 41.4 ± 3.0 44.4 ± 6.4
VD (μL) 224 ± 15 230 ± 11 225 ± 11 231 ± 19 232 ± 13 241 ± 28
VD/TLC (μL/mL) 184 ± 9 191 ± 11 191 ± 8 181 ± 18 183 ± 6 186 ± 18
CRS (μL/cm H2O) 51.2 ± 7.1 51.8 ± 5.8 46.7 ± 6.7 52.9 ± 4.2 54.1 ± 4.3 54.0 ± 8.0
CRS/TLC 41.2 ± 1.9 42.7 ± 1.5 39.3 ± 2.8* 41.2 ± 1.4 37.1 ± 1.5 41.5 ± 1.8
CL (μL/cm H2O) 70.7 ± 16 64.3 ± 11.9 57.3 ± 7.0* 71.9 ± 10.3 72.2 ± 7.0 64.2 ± 9.4
CL/TLC 57.1 ± 12.5 52.8 ± 6.5 48.4 ± 4.6* 55.8 ± 5.4 56.5 ± 3.8 49.5 ± 5.8
R (cm H2O/mL/s) 0.78 ± 0.20 0.84 ± 0.12 1.00 ± 0.21*
+ 0.84 ± 0.14 0.76 ± 0.18 0.93 ± 0.15
sR (cm H2O/s) 0.84 ± 0.40 1.01 ± 0.11 1.16 ± 0.19* 1.08 ± 0.18 0.98 ± 0.23 1.19 ± 0.13
DCO (μmol/min/hPa) 11.2 ± 2.8 11.9 ± 2.0 11.5 ± 1.5 15.9 ± 2.2 15.4 ± 2.0 15.3 ± 1.6
DCO/VA (μmol/min/hPa/mL VA) 9.3 ± 1.7 9.8 ± 1.5 10.3 ± 0.8 12.0 ± 0.8 11.6 ± 1.3 11.6 ± 1.1
DCO/VA (μmol/min/hPa/mL VA) 9.3 ± 1.7 9.8 ± 1.5 10.3 ± 0.8 12 ± 0.8 11.6 ± 1.3 11.6 ± 1.1
Mean ± SD, WT: wild type, Cftr+/−: heterozygous Cftr mutants, Cftr−/−: homozygous Cftr mutants, BW: body weight, TLC: total lung capacity, VD: series (Fowler) dead
space volume from helium expirogram, CRS: static compliance of respiratory system, CL: static lung compliance, R: respiratory system resistance, sR: specific
respiratory system resistance (R × TLC), DCO: single breath diffusing capacity for carbon monoxide (CO), VA: alveolar volume determined from helium tracings of
single breath diffusing capacity measurements, *: significant differences between aged matched wild type (WT) versus Cftr+/− or WT versus Cftr−/− , p < 0.05,
+: significant differences between age matched Cftr+/− versus Cftr−/−, p < 0.05.
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phagocytic particle uptake. There were no differences ob-
served in the diameters of NP-containing vesicles (dv) and
internalized TiO2NP (dNP) between Cftr mutant and WT
mice (Table 2). The distance of the particles to the vesicle
membrane (dP-M), however, was with 28.2 ± 38.2 nm sig-
nificantly (p = 0.026) smaller in macrophages of Cftr mu-
tants compared to 58.1 ± 76.2 nm in WT mice. There
were no significant differences in any of the parametersTable 2 Sizes of TiO2NP and vesicles, distance of TiO2NP to ve
Genotype NNP dV, nm
Cftr mutant
Epithelium, type 2 cells 5
Mean ± SD 245 ± 92
Range 168 - 347
Macrophages 14
Mean ± SD 409 ± 327
Range 101 - 1247
WT
Epithelium 0
Macrophages 18
Mean ± SD 450 ± 256
Range 183 - 857
NNP: Number of TiO2NP, dV: vesicle diameter, dNP: NP diameter, dNP-M: distance of N
difference to WT mice, p < 0.05, n = 2 per genotype.analyzed between NP in lung epithelial cells and in
macrophages.
There was no particulate titanium found in control
mice, which had been exposed to clean, filtered air.
Biokinetics of IrNP
We found no significant differences in total, regional and
head deposition of inhaled IrNP between Cftr mutant and
WT mice (Figures 3 and 4). Inhaled NP translocation fromsicle membrane
dNP, nm RV/P DNP-M, nm
37.7 ± 20.3 5.5 ± 1.4 47.6 ± 8.4
22.6 – 66.2 4.2 – 7.0 36 - 56
36.7 ± 11.5 11.6 ± 10.8 28.2* ± 38.2
20.7 – 59.7 2.6 – 37.8 7 - 156
40.7 ± 13.9 9.2 ± 4.6 58.1 ± 76.2
27.4 – 86.0 2.8 – 17.1 11 - 267
P to vesicle membrane, RV/P: ratio of vesicle to particle size, *: significant
Figure 2 Ultrastructural localization of TiO2NP in lung tissue. TiO2NP (arrows): A) in a vesicle of a macrophage that is closely associated with
the alveolar epithelium (arrow heads); a) high magnification micrograph of the NP-containing vesicle. B) in large vesicle of macrophage containing
lamellar structures (surfactant); b) high magnification micrograph of the NP-containing phagolysosome. C) and D), in vesicles of alveolar type 2 epithelial
cells. Note the close association of the TiO2NP to the vesicle membrane.
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gans was also not different between the two genotypes,
immediately (0 h) as well as 24 h after exposure to the NP
aerosol (Figure 5).
Inflammatory response to CNP
Histopathological examination of the lungs revealed
focal accumulation of particle-loaded macrophages and
granulocyte infiltrates with debris (alveolitis), which was
most pronounced at day 1 after CNP instillation. There
were no differences observed between Cftr mutant and
WT mice.Total BAL cell numbers in untreated controls were
comparable in both genotypes, i.e. 3.4 ± 0.6 × 105 in Cftr
mutants and 5.0 ± 1.6 × 105 in WT mice. Intratracheal in-
stillation of 20 μg CNP induced an acute BAL inflamma-
tory cell infiltration dominated by neutrophils at day 1,
which was equivalent in both animal groups (Figure 6).
The subsequent resolution of the inflammation, analyzed
at days 3 and 7 after CNP instillation, however, differed
significantly between the two animal groups. BAL neutro-
phils decreased fivefold from 35% at day 1 to 7% at day 3
in WT mice, compared to a twofold decrease from 27% to
13% in Cftr mutants. Despite of this difference at day 3,
Figure 3 Deposition of inhaled IrNP. A) Total deposition determined either immediately (0 h) or 24 h after a 1-h inhalation exposure; given
relative to the estimated inhaled aerosol. B) Head deposition determined immediately (0 h) after a 1-h inhalation exposure. No significant
difference of total and head deposition between the two animal groups.
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at day 7 in both animal groups. BAL lymphocyte and
macrophage numbers increased after CNP instillation as
well, though not statistically different between the two ani-
mal groups. In line with the lung response, peripheral
blood monocytes were significantly increased at days 1
and 3 in Cftr mutant compared to WT mice, and levelled
off at day 7 as well (data not shown).
The analysis of CNP-induced production of BAL cyto-
kines (IL-1α, -6, -12p40, -12p70, G-CSF, CXCL-1, -5,
CCL-3, -5) reflected the inflammatory response observed
at the leukocyte level, whereby most cytokine levels were
comparable between Cftr mutant and WT mice (Table 3,
Figure 7A). At day 3 after CNP instillation, however, the
inflammatory mediators G-CSF, CXCL5, CCL5, osteo-
pontin (OPN/SPP1) and lipocalin-2 (LCN2) were signifi-
cantly increased in Cftr mutant compared to WT miceFigure 4 Regional deposition of inhaled IrNP determined either imme
cleared fraction (A) estimates the airway deposition fraction including head
aerosol. The difference between 0 h and 24 h relates to the fact that fast c
24-h values are to be considered. No significant difference between the tw
retained IrNP. The difference between 0 h and 24 h relates to the fact that
retention. Therefore, only the 24-h values are to be considered for IrNP rete
two animal groups.(Table 3, Figure 7A/B). Most strikingly, G-CSF, which is
critical for the survival of granulocytes, was 13 times higher
in Cftr mutant compared to WT mice. This difference
matches well with the prolonged high number of BAL neu-
trophils and indicates increased survival and poor clearance
of BAL neutrophils in Cftr mutant mice. Additional immu-
nohistological analysis indicated focal expression of osteo-
pontin, a marker for inflammatory macrophages [25], at the
site of accumulation of particle-loaded macrophages and
accompanying cell debris.
BAL lipid mediator analysis revealed generally reduced
levels of 15(S)-HETE, a major anti-inflammatory arachi-
donic acid metabolite from the 15-lipoxygenase pathway
in Cftr mutants, statistically significant at days 1 and 3
after CNP instillation as well as after sham treatment
(Figure 7B). The lipid mediators, LTB4, lipoxin-A4 and
PGE2 remained unchanged (data not shown), except fordiately (0 h) or 24 h after a 1-h inhalation exposure. The fast
airways. Regional deposition is given relative to the totally deposited
learance is not finished after the 1-h inhalation. Therefore, only the
o animal groups. Peripheral lung retention (B) represents long-term
fast clearance is not finished after the 1-h inhalation, adding to lung
ntion in the peripheral lungs. No significant difference between the
Figure 5 Translocation of inhaled IrNP towards secondary target organs determined 24 h after the 1-h aerosol inhalation. No significant
difference between the two animal groups.
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Cftr mutants (48.6 ± 26.7 pg/mL) compared to WT mice
(447.2 ± 219.5 pg/mL) at day 3.
Discussion
In a comprehensive approach respecting possible multi-
factorial causes for enhanced susceptibility of CF lungs
to environmental PM exposure (Figure 1), we evaluated
whether structural or functional parameters of the Cftr
mutant lungs were affected by the mutation. Overall, we
have no indications for microstructural changes of the
peripheral lung, which is in agreement with our previous
findings [22,23]. While lung and airway volumes as well
as gas exchange capacity were not affected by the muta-
tion, we found moderate changes in lung resistance and
compliance. Since structural changes were not detect-
able, an altered homeostasis of the pulmonary lining
fluid may be a potential explanation. We also do not
have indications for altered deposition or biokinetics of
inhaled IrNP in the body.
However, despite finding an almost ‘normal lung’ in
Cftr mutants, there is evidence for alterations in the cel-
lular uptake of inhaled TiO2NP similar to findings weFigure 6 BAL cells after CNP instillation. Exposure to CNP led to a twofol
and 7. *: significant difference to WT mice, p < 0.05. CC: cage control (untreaterecently obtained for the uptake of inhaled 20-nm gold
(Au) NP in Scnn1b transgenic mice (airway targeted
overexpression of the epithelial Na + channel β subunit
Scnn1b), which mimic key aspects of chronic obstructive
lung diseases in humans [20]: (i) The uptake of a sub-
stantial part of the NP (26%) by alveolar epithelial cells
in Cftr mutants points to less efficient TiO2NP uptake
by surface macrophages in these mice. This may pro-
mote depth translocation of the NP, for which, however,
we obtained no evidence from the data of the biokinetic
study with IrNP. Enhanced interaction of NP with epi-
thelial cells may induce or alter inflammatory responses,
as we have observed -and which we discuss in detail
below- in Cftr mutants after exposure to CNP. As in a
previous inhalation study with 20-nm TiO2NP in rat
lungs [26], we did not observe TiO2NP bound to the ap-
ical surface of epithelial cells. (ii) The localization of
TiO2NP in vesicles largely exceeding NP size (RV/P > > 1)
in all cell types and in both animal groups indicates
endocytic uptake of the NP. This finding is in agreement
with other reports on intra-vesicular particle localization,
suggesting NP uptake by cells to mainly occur by endo-
cytic processes [27]. (iii) The close localization of NP tod increase of BAL neutrophils in Cftr mutants at day 3, but not at days 1
d animals); Sham: instillation of 50 μL pyrogene-free distilled water.
Table 3 BAL cytokines
A) Cytokines (MultiPlex assay)
Genotype Treatment IL-1a IL-6 IL-12(p40) IL-12(p70) G-CSF CXCL1 CCL3 CCL5
pg/mL ± pg/mL ± pg/mL ± pg/mL ± pg/mL ± pg/mL ± pg/mL ± pg/mL ±
WT CC 3.5 0.2 5.7 - 1.4 - 4.0 - 1.2 - 2.5 0.2 49.3 - 1.6 -
Sham 7.7 2.4 5.4 0.3 2.3 0.3 4.3 0.2 1.5 0.3 5.6 2.5 100.1 28.6 3.8 1.3
CNP d1 6.4 0.8 54.4 9.1 4.5 1.5 4.2 0.2 105.5 30.6 104.4 21.3 103.7 20.1 2.4 0.3
CNP d3 4.2 0.5 5.7 - 11.1 8.1 4.0 - 9.4 3.6 10.7 4.0 66.2 12.7 12.7 6.4
CNP d7 4.9 0.5 5.7 - 4.2 1.1 4.0 - 1.3 0.1 8.6 2.5 100.9 17.2 9.0 4.0
Cftr mutant CC 6.9 0.6 5.7 - 2.6 0.3 4.0 - 1.2 - 3.6 0.4 101.4 6.6 5.1 0.5
Sham 7.7 0.8 5.7 - 3.2 0.3 3.7 0.3 1.2 - 2.9 0.3 79.5 15.0 3.2 0.7
CNP d1 11.7* 3.7 95.3 29.8 6.0 1.3 4.5 0.2 156.1 59.0 92.4 24.0 129.7 22.2 2.8 0.4
CNP d3 4.2 0.6 14.0 5.3 15.4 4.6 4.7 0.6 125.3* 73.5 8.6 1.0 99.6 18.3 35.4* 16.3
CNP d7 4.0 0.5 5.7 - 7.2 1.8 3.9 0.2 1.2 - 13.8 1.7 93.2 28.9 11.6 3.8
B) Cytokines (ELISA assay)
Genotype Treatment CXCL5 LCN2 GAL3 OPN
pg/mL ± ng/mL ± ng/mL ± ng/mL ±
WT CC 70.0 14.7 20.9 1.3 7.0 4.4 5.9 0.6
Sham 22.5 2.0 22.4 1.4 14.1 0.8 4.7 1.0
CNP d1 423.7 70.6 226.0 36.5 18.8 2.9 12.3 2.8
CNP d3 145.7 51.2 101.8 15.6 13.1 3.1 20.3 8.9
CNP d7 241.1 26.0 63.9 16.2 12.2 1.0 21.2 3.1
Cftr mutant CC 49.2 4.2 12.3 1.4 23.8* 2.4 5.8 2.0
Sham 25.1 3.4 8.7 7.2 13.9 0.9 6.3 1.9
CNP d1 413.5 55.6 163.7 32.6 19.0 3.2 13.8 1.6
CNP d3 252.5* 31.5 181.6* 31.6 17.9 2.3 46.2* 4.8
CNP d7 207.4 50.1 72.0 11.1 10.1 3.1 25.9 2.8
Mean ± SD, *: significant difference to corresponding value in WT mice, p < 0.05, CC: cage control (untreated animals), Sham: instilled with 50 μL pyrogen-free
distilled water.
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NP attached to the cell surface, resulting in internalization
of the material by endocytosis. This correlates with findings
in the above mentioned inhalation studies in rodents with
TiO2 and Au nanoparticles [26,20]. In the latter study, fast
attachment of AuNP to lung cells has been demonstrated
[26]. Monocyte/macrophage expressed CFTR protein has
recently been described to not only support phagolysoso-
mal acidification but also contribute to the opsonization
and phagocytosis of particles and bacteria [28]. Data show-
ing the statistically significant reduction of dNP-M in Cftr
mutant compared to WT mice in the present study support
this idea. The absence of CFTR protein in the macrophage
membrane may have resulted in smaller particle-protein
complexes, with possible consequences for the efficacy of
particle uptake in macrophages. In addition, internalized
particles would appear closer to the vesicle membrane. Be-
sides receptor binding, adhesion forces may represent an al-
ternative mechanism for the close localization of AuNP to
the vesicle membrane [29]. In this case, however, we wouldexpect dNP-M values near 0. In addition, adhesion forces
provide no explanation for the recorded difference in dNP-M
between Cftr mutant and WT mice.
In addition to altered cellular uptake of TiO2NP in Cftr
mutants, changes in the resolution of the inflammation in
response to CNP exposure in these mice provide experi-
mental support for the finding of an increased susceptibil-
ity of CF patients to environmental PM exposure [12].
While CNP instillation induced an acute alveolitis equally
in Cftr mutant and WT mice at day 1, there were twice as
much BAL neutrophils in Cftr mutant compared to WT
mice at day 3. Thus, at day 3, 70% of the neutrophils were
already removed in WT mice compared to 23% in Cftr
mutants. The slower decline of BAL neutrophils indicates
delayed or impaired resolution of the inflammation in Cftr
mutant mice. This is further supported by the rate of the
neutrophils’ decrease from day 3 to 7, which remained ba-
sically unchanged in Cftr mutants, whereas it was biphasic
in WT mice (Figure 8A). Recruitment of macrophages
and lymphocytes was apparently not affected in Cftr
Figure 7 BAL cytokines and lipid mediators after CNP instillation. A) Heat map of cytokines. Black boxes indicate lowest and bright red
highest detected levels for each cytokine (according to Table 3). Cytokines have been sorted by the response pattern. IL-1a, IL-6, and CXCL1 showed
highest levels at day 1 after CNP exposure, CCL5, OPN, and IL-12p40 at day 3. Overall elevated cytokine levels were observed in Cftr mutant (−/−) as
compared to WT (+/+) mice. B) 15-HETE. Increase over time after instillation treatment in WT mice, but independently of the CNP exposure; 15-HETE
was generally reduced in Cftr mutant mice (hatched bars). *: significant difference to WT animals, p < 0.05. CC: cage control (untreated animals); Sham:
instillation of 50 μL pyrogene-free distilled water.
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were similar in both animal groups.
Besides the acute response peaking at day 1, BAL cyto-
kine profiling also indicated higher concentrations of G-
CSF, CCL3, CCL5, CXCL5, LCN2, OPN and IL-12p40 at
day 3 in Cftr mutant compared to WT mice. Thereby,
the increases in CCL5, OPN and IL-12p40 in Cftr mu-
tants indicate inflammatory-stimulated macrophages,
which are important producers of G-CSF. Increased
levels of CXCL5 and LCN2 indicate inflammatory stimu-
lation of the epithelium attracting neutrophils. Conse-
quently, increased G-CSF levels until day 3 supports the
survival and persistence of the otherwise short-lived
neutrophils in Cftr mutants. Thus, the congruent cellular
and molecular data, which are summarized in Figure 8B,
suggest that an impaired resolution of the inflammation
causes increased neutrophil numbers at day 3 in Cftr
mutant mice rather than escalating recruitment of in-
flammatory cells during the initiation phase. The gener-
ally significantly lower levels of BAL 15-HETE in Cftr
mutant compared to WT mice further suggests an asso-
ciation of this lipid mediator with the compromised
resolution of CNP-induced airway inflammation in Cftr
mutants. The eicosanoid 15-HETE is not only expressed
by leukocytes but also by the respiratory epithelium [30],
and it is known as an anti-inflammatory and pro-
resolving lipid mediator, which counteracts neutrophilic
airway inflammation [31]. In humans, the 15-keto-PGE2–PPAR-γ system has been suggested to regulate
abnormal mucus production in CF, with the unsaturated
fatty acid derivate 15-keto-PGE2 and 15-HETE repre-
senting crucial PPAR-γ ligands [32].
In summary, despite lacking significant alterations in
lung deposition and biokinetics of inhaled NP and absence
of significant differences in lung function and structure, al-
terations in cellular uptake of inhaled TiO2 and the signifi-
cantly enhanced, acute inflammatory responses to NP
exposure indicate a moderately increased susceptibility of
Cftr mutant lungs.
Conclusions
Our results lead to the conclusion that the function of
the CFTR gene, to the extend as investigated here in the
CftrTgH (neoim) Hgu mouse line, is dispensable for lung func-
tion development as well as to mechanisms required for
nanoparticle deposition or translocation. In contrast, the ab-
sence of CFTR appeared to modify cellular uptake of NP
and caused a moderate impairment of the resolution of a by
particle instillation induced neutrophilic airway inflamma-
tion. While the described effects might not be alarming for
a single exposure to NP under aseptic conditions, the lungs
of a CFTR deficient organism may be more susceptible to
repetitive or chronic exposures to inflammatory stimuli like
particulate air pollution and airway infection. Under these
conditions, insufficiently resolved inflammation might pro-
mote the development of chronic inflammatory lung disease.
Figure 8 Neutrophilic inflammation and its resolution in CF airways. A) Time course of BAL neutrophils after CNP instillation showing a
slower decline of BAL neutrophils from days 1 to 7 in Cftr mutant compared to WT mice. *: significant difference to WT animals, p < 0.05. B) Mode
of action for impaired inflammation resolution in CF airways. The accumulation of inflammatory cells (PMN) in Cftr mutant lungs at day 3 after
particle exposure is probably supported by different pathways: Augmented CXCL5 levels, released from Cftr mutant inflammatory epithelial cells,
enhance exposure-related PMN recruitment and accumulation on the airway surface. In addition, elevated G-CSF and reduced 15-HETE levels in
Cftr mutant lungs contribute to prolonged PMN survival and impaired efferocytosis of apoptotic PMN by macrophages. PMN: Polymorphnuclear
cells = neutrophils, AM: Airway macrophages, AEC: airway and alveolar epithelial cells, EC: endothelial cells.
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Experimental design
To resolve mechanisms contributing to enhanced sus-
ceptibility to inhaled NP in Cftr mutants (Figure 1A), we
studied (i) lung function prior to NP exposure, (ii) NP
distribution in lung cells immediately (0 h) and 24 h
after a 1-h exposure to 20-nm TiO2 aerosol, and (iii) NP
biokinetics within 24 h after exposure to radio-labeled
30-nm Ir aerosol (Figure 1B). Finally, (iv) inflammatory
responses were determined at days 1, 3 and 7 after intra-
tracheal instillation of carbon NP (CNP, mean agglomer-
ate size 210 nm), in Cftr mutant mice with no signs of
lung disease and in WT littermates.Animals
Origin, genetics, husbandry
CftrTgH (neoim) Hgu transgenic (Cftrtm1HGU) mice created
by targeted insertional mutagenesis have markedly de-
creased CFTR activity [21,33]. They survive to adulthood
and have a phenotype resembling that of human compound
heterozygotes. Although these mice – like most other CF
mouse models – do not develop lung disease spontaneously,
Cftrtm1HGU mice develop pathogen-specific lung disease
after bacterial challenge; they are more easily infected and
develop more severe lung pathology than non-cf mice [34].
Uninfected Cftrtm1HGU mice have a normal fine pulmonary
structure including the lung lining layer [22,23].
Geiser et al. Particle and Fibre Toxicology 2014, 11:19 Page 11 of 15
http://www.particleandfibretoxicology.com/content/11/1/19Cftr mutant and WT mice (MF1, Charles River, Sulzfeld,
Germany) were bread and reared in the animal facility of
the Institute of Lung Biology and Disease at the Helmholtz-
Center Munich, Neuherberg/Munich, Germany. Mice were
housed in individually ventilated cages (IVC; BioZone,
Ramsgate, UK) supplied with filtered air and access to food
and water ad libitum. They were kept on a 12 h day/night
cycle, humidity was maintained at 55% and the temperature
of the control room was 22°C. Mouse progeny were geno-
typed by tail biopsy polymerase chain reaction (PCR) using
the genotyping primers HGU-Neoplas-KO1: 5′-AAA GTG
TAA AGC CTG GGG TGC-3′ and HGU-NeoAS-KO2:
5′-AGA ACT CGT CAA GAA GGC GAT AG-3′ generat-
ing a 3691 bp KO-product and HGU-Int9-WT1: 5′-GGA
GCC TAG CAT AGA TGT CTC C-3′ and HGU-M10B-
WT2: 5′-CTG CTG TAG TTG GCA AGC TTT GAC-3′
generating a 3274 bp WT-product (PCR conditions: 33×
94°C 30 sec, 64°C 30 sec, 72°C 2 min). Specified pathogen-
free status was approved by a health certificate according to
Federation of European Laboratory Animals Science Asso-
ciation (FELASA) guidelines.
Animals were treated humanely and with regard for al-
leviation of suffering. All experiments were conducted
under federal guidelines for the use and care of labora-
tory animals and were approved by the Bavarian Animal
Research Authority and by the Helmholtz Center’s Insti-
tutional Animal Care and Use Committee, as well as in
accordance with the Swiss Federal Act on Animal Pro-
tection and the Swiss Animals Protection Ordinance.
Nanoparticles
We selected the three different NP types for the following
technical reasons: Biokinetics of inhaled NP particles: Irid-
ium and titanium dioxide NP, since we previously devel-
oped reliable techniques of stably radio-labeling the IrNP
[35,36] and elemental microanalysis by EFTEM for unam-
biguous identification of the TiO2NP [37]. The sensitivity
of the radio-analysis allowed administering low doses in
the μg range during a rather short 1-2-hour inhalation,
thereby avoiding any toxicological side effects by the NP
used. Besides the appropriate radio-analysis of both NP,
identification of NP by EFTEM allowed elemental map-
ping of individual TiO2NP at the ultrastructural level in
the tissue.
Inflammatory response of the lung: The comparative
investigation of toxicological effects of NP in Cftr mu-
tant and WT mice required applying higher NP doses,
such that an acute inflammatory response was induced.
Since carbon nanoparticles are most relevant for envir-
onmental exposure, pure elemental CNP were adminis-
tered by intratracheal instillation [38]. The latter method
allowed reproducible and well controlled NP dosing,
which was important to compare toxicological responses
to NP in Cftr mutant and WT mice. However, this bolusapplication is less physiological than inhalation. The de-
position pattern of instilled NP is different from that of in-
haled NP. The target tissue of instilled and inhaled NP,
however, remains the same, as NP are deposited on the
epithelium of airways and alveoli. Since the lungs of our
animals were “sterile” prior to NP treatments, there was
no pre-existing lung pathology with excess mucus produc-
tion. In addition, we have previously performed compre-
hensive characterization of all three NP (IrNP: [35,36];
TiO2NP: [37,39]; CNP: [38,40,41]). Thereby, we have
shown that the morphology of all three particle types was
very similar (see also Figure 9), namely chain-aggregated/
agglomerated NP consisting of primary particles in the
size range of about 5 nm (CNP: 5 - 12 nm).
Lung distribution and clearance of inhaled TiO2 aerosols
Three Cftr mutant and three WT mice (female, aged 10 -
12 weeks, body weight 17.7 - 20.8 g) were used. There
were no significant differences in age or body weight be-
tween mutant and WT mice. For particle inhalation, ani-
mals were deeply anaesthetized by intraperitoneal (i.p.)
injection of a mixture of medetomidine (Domitor®, Pfizer
GmbH, Karlsruhe, Germany; 500 μg/Kg), midazolam
(Dormicum®, Hoffmann-La Roche AG, Grenzach-Wyhlen,
Germany; 5 mg/Kg) and fentanyl (Fentanyl®, Janssen-Cilag
GmbH, Neuss, Germany; 50 μg/Kg). For lung fixation im-
mediately after inhalation, anesthesia was deepened with
i.p. injection of a mixture of xylazin (Rompun®, Bayer Vital
GmbH, Leverkusen; 5 mg/Kg) and ketamine (Ketamin
10%, WDT eG, Garbsen, Germany; 100 mg/Kg) prior to
exsanguination by cutting the abdominal aorta. For 24-h
examinations, anesthesia was antagonized by subcutane-
ous injection of atipamezole (Antisedan®, Pfizer GmbH
Karlsruhe, Germany; 2.5 mg/kg), flumazenil (Anexate®,
Hoffmann-La Roche AG, Grenzach-Wyhlen, Germany;
500 μg/Kg), and naloxone (Narcanti®, Janssen Animal
Health, Neuss, Germany; 1.2 mg/Kg). For lung fix-
ation at 24 h, a mixture of xylazin and ketamine was
injected prior to euthanasia by exsanguination as above.
TiO2 aerosols, particle inhalation and deposition
TiO2 aerosol generation and inhalation were performed
as previously described [39,26]. Briefly, ultrafine anatase
TiO2 aerosols were generated with a Palas spark gener-
ator, quasi-neutralized with a radioactive 85Kr source, di-
luted and conditioned for inhalation in terms of gas
composition, humidity and temperature. Particle size
distribution and total number concentration were con-
tinuously monitored by a differential electrical mobility
particle sizer (DMPS) and a condensation particle coun-
ter (CPC). The aerosol produced had a count median
diameter (CMD) of about 20 nm (geometric standard
deviation, GSD = 1.6) and a mean number concentration
of 1 - 2 × 1013 particles/m3, resulting in a mass concentration
Figure 9 Morphology of nanoparticles. Chain-aggregated/agglomerated NP consisting of primary particles in the size range of about 5 nm
(CNP: 5 - 12 nm). A) IrNP, B) TiO2NP and C) CNP.
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sampled for morphologic analysis on filters and on
formvar-coated copper grids using a TEM particle sam-
pler (Fachhochschule Nordwestschweiz FHNW, Windisch,
Switzerland).
The deeply anesthetized mice were placed in airtight
plethysmograph boxes for 1 h and inhaled the aerosols
via an endotracheal tube by negative-pressure ventilation
(-1.5 kPa) at a tidal volume of about 170 μl and a breath-
ing rate of 120/min resulting in a minute ventilation of
20 cm3/min, which is 20% more than in spontaneously
breathing mice. This inhalation protocol optimized NP
deposition per exposure time. The deposited amount of
TiO2 was calculated to be 0.1 μg or 7 × 10
9 NP in each
Cftr mutant or WT mouse lung (assuming a 40% depos-
ition probability).
Two additional mice (one Cftr mutant and one WT)
were not subjected to aerosol inhalation and served as
controls.
Organ and tissue processing for microscopic analysis
To analyze the distribution of inhaled TiO2NP in lung
cells at the individual particle level, organs were fixed in
situ by instillation of phosphate-buffered 2.5% glutaral-
dehyde (350 mOsm, pH 7.4) at a pressure of 20 - 25 cm
H2O as described previously [22]. Thereafter, lungs were
removed in toto from the thorax and stored for at least
24 h in fixative solution at 4°C. Lung volumes [42] were
0.70 - 0.95 mL in Cftr mutant and 0.62 - 0.82 mL in WT
mice and were not significantly different between the
two animal groups.
Lungs were then subjected to systematic tissue sam-
pling, post fixation with osmium tetroxide and uranyl
acetate (Sigma-Aldrich, Buchs, Switzerland), dehydration
in ethanol and embedding in epon (Sigma-Aldrich) as
described previously [37,43]. Ultrathin sections (≤50 nm)
were cut from 5 - 6 tissue blocks per animal, mounted onto
formvar coated 600-mesh hexagonal copper grids and
stained with uranyl acetate and lead citrate (Ultrastain;
Leica, Glattbrugg, Switzerland).TiO2NP were identified on ultrathin tissue sections by
EFTEM using a LEO 912 TEM (Zeiss, Oberkochen,
Germany) equipped with an in-column omega energy
filter and operated at 120 kV as described previously
[37]. Electron spectroscopic imaging (ESI) was per-
formed with an energy slit width of 10 eV at the titanium
L-edge at 464 eV using the three-window method imple-
mented in the iTEM software (Olympus, Muenster,
Germany). On each ultrathin section, we determined a
random starting point from which we meander-like ana-
lyzed every fourth hexagonal field for the presence of
TiO2NP and its anatomical-histological and (sub) cellu-
lar localization. In addition, on each ultrathin section all
surface macrophages were sampled and analyzed for
TiO2NP.
Finally, sections of ~ 1 μm thickness were cut from the
sampled tissue blocks and stained with toluidine blue to
evaluate the fine pulmonary structure by estimating the
corresponding ratios with a point counting system.
Lung physiology
Lung function was determined in anesthetized and intu-
bated, 14-week old male and female Cftr mutant (n = 35)
and WT (n = 16) mice as described previously [44,45]. It
covers lung volumes, conducting airway volume, respira-
tory mechanics and gas exchange capacity. Body weight
in females was significantly lower than in their male
counterparts, the difference was 24% in Cftr mutants
and 29% in WT mice (for details see Table 1).
Deposition and biokinetics of inhaled IrNP
Sixteen female Cftr mutant and 16 WT mice (age: 10 -
12 weeks; body weight: 20 - 22 g) were used for bioki-
netic studies. Radiolabeled Ir (192Ir) aerosols of 30 nm
CMD (GSD = 1.6) were generated as described for TiO2
above; the mean aerosol concentration was 3 × 106 parti-
cles/cm3. Anesthetized mice inhaled the aerosol for 1 h
during spontaneous breathing in a nose-only apparatus
described previously for NP exposure of newborn rats
[46]; about 2 × 109 particles corresponding to 0.9 μg
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described above and euthanized either immediately (0 h)
or 24 h after the 1-h aerosol inhalation.
Organs were harvested and Ir was analyzed quantitatively
by gamma-spectrometry in all organs and tissue samples,
as well as the remaining carcass and the excretion.
Inflammation
Thirty nine Cftr mutant and 30 WT mice (female, age:
9 – 11 weeks, body weight: 19.1 - 22.3 g) were used to in-
vestigate the course of CNP induced lung inflammation.
CNP generation and instillation
CNP were generated by spark discharge from graphite
electrodes (GFG1000, Palas, Karlsruhe, Germany) [47].
They mimic combustion-derived particles with low or-
ganic carbon content, large specific surface area
(800 m2/g), as well as structural and compositional simi-
larities to modern (Euro IV) diesel soot [48]. The physi-
cochemical characteristics of CNP have been described
in detail earlier [38,40,41]. Anesthetized mice were intu-
bated by a nonsurgical technique and instilled with an
aqueous suspension of 20 μg CNP in 50 μL pyrogen-free
distilled water, followed by 100 μL of air [38,49]. The
suspension of poorly soluble CNP was sonicated on ice
for 1 min prior to instillation, using a SonoPlus HD70
(Bachofer, Berlin, Germany) at a moderate energy of
20 W to ensure sufficient particle dispersion with a
mean agglomerate size of 210 nm (Zetasizer Nano ZS,
Malvern Instruments, Herrenberg, Germany). Control
animals were either instilled with 50 μL of pyrogen-free
distilled water (Sham), or left undisturbed in their cages
(cage control, CC).
Sample collection and preparation for inflammation
analysis
Anesthetized mice were euthanized by exsanguination at
days 1, 3 and 7 after CNP instillation. Blood was with-
drawn from the retro orbital plexus with a capillary and
collected in EDTA coated tubes (Sarstedt, Germany) for
hematological analysis (ADVIA Hematology Systems
(Bayer Diagnostics). Lungs were lavaged with 10 × 1 mL
phosphate buffered saline (PBS, calcium and magnesium
free) as described previously [38]. The BAL fluids from
the first two lavages were used for protein analysis after
cell separation by centrifugation (425 × g, 20 min at room
temperature). The cell pellet was resuspended in 1 mL
RPMI 1640 medium (BioChrome, Berlin, Germany) sup-
plemented with 10% fetal calf serum (Seromed, Berlin,
Germany). Cell viability was determined by the Trypan
blue dye exclusion test. Differential cell counts were per-
formed on cytospin preparations (May-Grünwald-Giemsa
staining; 2 × 200 cells were counted).BAL protein analysis
Total BAL protein content was determined spectrophoto-
metrically with an ELISA reader (Labsystems iEMSReader
MF, Helsinki, Finland) at 620 nm, using the Bio-Rad Pro-
tein Assay Dye Reagent (no. 500-0006; BioRad, Munich,
Germany).
Cytokine analysis in BAL fluid was performed using the
Bio-Plex bead-based suspension array system and the
appropriate detection kits (Pro Mouse 10Plex, Bio-Rad,
Hercules CA, USA) and specific ELISAs (mouse, R&D Duo
Sets) for osteopontin (OPN/SPP1, catalog number DY441),
galectin-3 (DY1197), LIX/CXCL5 (DY443) and lipocalin-2
(NCL2/NGAL, DY1857) as described previously [49].
Lung concentrations of the lipid mediators 15(S)-
HETE and PGE2 were assessed as follows: Lung homog-
enates (about 50 mg lung tissue/500 μL) were prepared
by disrupting lung tissue in HEPES buffer, pH 7.4, with
lysing matrix E (FastPrep FP120 cell disrupter; MP Bio-
medicals Germany GmbH, Eschwege, Germany). After
centrifugation (3200 × g at 4°C for 10 min), aliquots of
the supernatants were taken for determination of protein
and lipid mediators. Aliquots of supernatants derived
from cell homogenates of particle-treated cells (prepared
as described above) and those from lung homogenates
were deproteinized by adding an 8-fold volume of 90%
methanol containing 0.5 mM EDTA and 1 mM
4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, pH 7.4
[50]. Methanol suspensions were stored at -40°C for 24 h
followed by two centrifugation steps at 10,000 × g for
20 min at 4°C with a 24 h interval to remove the proteins.
Aliquots of the obtained supernatants were dried in a vac-
uum centrifuge, dissolved in assay buffer and used for
quantification of PGE2, Lipoxin-A4 and 15(S)-HETE by
their specific enzyme immunoassays (Cayman Chemical
Company, Ann Arbor, MI, USA) according to manufac-
turer’s protocol. Protein was measured at 595 nm using
5 μL of homogenate and 200 μL of 1:5 diluted BioRad so-
lution (Bio-Rad, Munich, Germany) with bovine serum al-
bumin as standard.
Histopathology and immunohistochemistry
Two to three mice of each group were sacrificed for
histopathological and immunohistochemical examina-
tions after CNP instillation. Lungs were fixed without
lavage in phosphate buffered saline (pH 7.4) and 4% for-
malin at an inflation pressure of 20 cm H2O and embed-
ded in paraffin.
Since we have previously shown that osteopontin (OPN/
SPP1) expression is induced in alveolar macrophages at
day 1 after CNP inhalation [25] and SPP1 concentration
was found to be increased in BAL fluid, we performed im-
munohistochemical analysis of osteopontin in lung sections
using a polyclonal antibody (R&D Systems, Wiesbaden,
Germany). After staining with a biotinylated secondary
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USA) and streptavidin-Vectastain Elite ABC peroxidase re-
agents (Vector Laboratories Inc.), lung sections were devel-
oped with Nova Red (Vector Laboratories Inc.) and
counterstained with hematoxylin.
Statistics
Lung physiology, deposition, distribution and biokinetics
of inhaled NP: The non-parametric Mann–Whitney Test
was used for two group comparisons and one-way analysis
of variance (ANOWA) for multiple group comparisons.
Inflammation: Two-way ANOVA was used to analyze dif-
ferences between control and various exposure groups.
Group means of WT and Cftr mutant mice were com-
pared using the Student’s t-test. Overall, a significance
level of p < 0.05 was adopted.
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